Warning! GuruFocus detected
1 Severe warning sign
with CNTA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Centessa Pharmaceuticals PLC
ISIN : US1523091007
Share Class Description:
CNTA: ADRDescription
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.11 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | -0.53 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | -17.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.12 | |||||
| 9-Day RSI | 21.39 | |||||
| 14-Day RSI | 27.69 | |||||
| 3-1 Month Momentum % | -4 | |||||
| 6-1 Month Momentum % | 2.45 | |||||
| 12-1 Month Momentum % | 57.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.25 | |||||
| Quick Ratio | 9.25 | |||||
| Cash Ratio | 8.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.8 | |||||
| Shareholder Yield % | -23.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -71.92 | |||||
| ROA % | -51.84 | |||||
| ROIC % | -289.52 | |||||
| ROC (Joel Greenblatt) % | -1802.92 | |||||
| ROCE % | -53.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.84 | |||||
| Price-to-Tangible-Book | 3.84 | |||||
| EV-to-EBIT | -5.34 | |||||
| EV-to-EBITDA | -5.37 | |||||
| EV-to-FCF | -8.38 | |||||
| Price-to-Net-Current-Asset-Value | 4.28 | |||||
| Price-to-Net-Cash | 5.03 | |||||
| Earnings Yield (Greenblatt) % | -18.73 | |||||
| FCF Yield % | -9.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CNTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Centessa Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.99 | ||
| Beta | 1.45 | ||
| 3-Year Sharpe Ratio | 0.51 | ||
| 3-Year Sortino Ratio | 0.84 | ||
| Volatility % | 49.94 | ||
| 14-Day RSI | 27.69 | ||
| 14-Day ATR ($) | 1.170144 | ||
| 20-Day SMA ($) | 15.3995 | ||
| 12-1 Month Momentum % | 57.47 | ||
| 52-Week Range ($) | 7.75 - 19.09 | ||
| Shares Outstanding (Mil) | 133.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Centessa Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Centessa Pharmaceuticals PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Centessa Pharmaceuticals PLC Frequently Asked Questions
What is Centessa Pharmaceuticals PLC(CNTA)'s stock price today?
The current price of CNTA is $11.68. The 52 week high of CNTA is $19.09 and 52 week low is $7.75.
When is next earnings date of Centessa Pharmaceuticals PLC(CNTA)?
The next earnings date of Centessa Pharmaceuticals PLC(CNTA) is 2025-05-13 Est..
Does Centessa Pharmaceuticals PLC(CNTA) pay dividends? If so, how much?
Centessa Pharmaceuticals PLC(CNTA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers